The FDA may allow broader access to testosterone therapy for men with low libido without known medical cause. Manufacturers ...
By contrast, at almost every turn, the Trump administration has made it more difficult for transgender men and nonbinary ...
The US Food and Drug Administration (FDA) is asking makers of testosterone replacement therapy (TRT) products to consider ...
“New and emerging data suggest there may be an opportunity to help men suffering from symptoms that significantly affect ...
The FDA is encouraging TRT manufacturers to seek a new indication for low libido in men with idiopathic hypogonadism.
April 16 (Reuters) - The U.S. Food and Drug Administration is considering approving testosterone replacement therapy to treat ...
Stocktwits on MSN
HIMS stock's rally may have plenty of room left: FDA opens door to testosterone therapy
The FDA signaled openness to expanding testosterone therapy use for low libido linked to idiopathic hypogonadism, a condition without a known cause. ・Hims began building its testosterone-care platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results